Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Nov 6:16:44.
doi: 10.1186/s40200-017-0327-1. eCollection 2017.

Successful glycemic control using a flash glucose monitoring system for a pregnant woman with diabetes: a case report

Miyako Kishimoto  1   2 , Saori Tamada  3 , Yoko Oshiba  1   3
Affiliations
Case Reports

Successful glycemic control using a flash glucose monitoring system for a pregnant woman with diabetes: a case report

Miyako Kishimoto et al. J Diabetes Metab Disord. .

Abstract

Background: Glucose control for pregnant women with glucose intolerance is important, as hyperglycemia may adversely affect the mother and the fetus.

Case presentation: We report the case of a pregnant Japanese woman who experienced gestational diabetes mellitus during her first pregnancy and developed impaired glucose tolerance after the delivery. During her second pregnancy with twins, she required up to 75 units of injected insulin to control her postprandial hyperglycemia and occasionally experienced hypoglycemia. We used a newly developed flash glucose monitoring system, which allowed her to successfully achieve ideal glycemic control and experience an uncomplicated delivery.

Conclusion: We suggest that this flash glucose monitoring system may be clinically effective for similar cases that involve pregnant women with abnormal glucose tolerance.

Keywords: Flash glucose monitoring system; Gestational diabetes mellitus; Impaired glucose tolerance; Insulin.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 and 2008. A written informed consent was obtained from the patient prior to the use of the FGM system. This case report was approved by the Ethics Committee of the Sanno Hospital.

Consent for publication

We obtained written informed consent from the patient for publication.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
The results of continuous glucose monitoring using the sensor-based flash glucose monitoring system. The arrows indicate the timing of the patient’s meals and insulin injections. The numbers above the arrows indicate the numbers of the units for each insulin injection. The patient needed 57 units of injected insulin on day 8 (2200 kcal in 5 meals) (a), 43 units of injected insulin on day 10 (1960 kcal in 5 meals) (b), 35 units of injected insulin on day 17 (1960 kcal in 4 meals) (c), 18 units injected insulin on day 38 (1960 kcal in 4 meals) (d), and no injected insulin at 3 days after the delivery (2200 kcal in 3 meals) (e)
See this image and copyright information in PMC

References

    1. Chen P, Wang S, Ji J, et al. Risk factors and management of gestational diabetes. Cell Biochem Biophys. 2015;71:689–694. doi: 10.1007/s12013-014-0248-2. - DOI - PubMed
    1. HAPO Study Cooperative Research Group. Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991–2002. doi: 10.1056/NEJMoa0707943. - DOI - PubMed
    1. American Diabetes Association Management of diabetes in pregnancy. Sec. 13. In standards of medical Care in Diabetes-2017. Diabetes Care. 2017;40(Suppl.1):S114–S119. doi: 10.2337/dc17-S016. - DOI - PubMed
    1. Holmes VA, Young IS, Patterson CC, et al. Diabetes and Pre-eclampsia Intervention Trial Study Group. Optimal glycemic control, pre-eclampsia, and gestational hypertension in women with type 1 diabetes in the diabetes and pre-eclampsia intervention trial. Diabetes Care. 2011;34:1683–1688. doi: 10.2337/dc11-0244. - DOI - PMC - PubMed
    1. Dabelea D, Hanson RL, Lindsay RS, et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes. 2000;49:2208–2211. doi: 10.2337/diabetes.49.12.2208. - DOI - PubMed

Publication types

LinkOut - more resources